文献速递神经免疫认知障碍与痴呆

儿童MOGAD中央静脉征与顺磁性边缘病灶的频率及转归研究

Investigating the Frequency and Outcome of Central Vein Sign and Paramagnetic Rim Lesions in Children With MOGAD.
PubMed 文献 · Neurology · 2026-01-09

该多中心回顾性纵向研究评估了65例儿童MOGAD患者共130次扫描中中央静脉征(CVS)与顺磁性边缘病灶(PRLs)的患病率及纵向变化。共分析520个病灶,CVS见于29.7%的可分析病灶,49.2%的患者至少有一个CVS+病灶;未发现PRLs。CVS+病灶消退率低于CVS-病灶,且CVS检出率在缓解期高于急性期。

要点

  • 儿童MOGAD中CVS可见于约三成可分析病灶,但未发现PRLs。
  • CVS+病灶较CVS-病灶更不易消退,提示CVS标记持续病灶。
  • MRI采集时机影响CVS检出,缓解期检出率高于急性期。

核心结论

  • 儿童MOGAD病灶病理生物学具有异质性,CVS标记持续而非一过性病灶,未发现PRLs支持其鉴别MOGAD与MS的潜在价值。

研究设计与样本

  • 纵向回顾性多中心研究,纳入65例有≥1个脑病灶、接受易感性成像且随访MRI间隔至少3个月的儿童MOGAD患者,共130次扫描。

主要发现

  • 520个病灶中CVS见于97/327(29.7%)可分析病灶,32/65(49.2%)患者至少有一个CVS+病灶。
  • 有≥1个CVS+病灶的患者病灶总数更多(p=0.002)且适合CVS分析的病灶更多(p<0.001)。
  • 31例有≥3个脑病灶的患者中,11/31(35.5%)有>40% CVS+病灶,7例(22.5%)有>50% CVS+病灶。
  • 急性发作期采集易感性成像的患者CVS+病灶比例低于缓解期(16% vs 33%,p=0.015)。
  • CVS-病灶消退率高于CVS+病灶(177/230,76% vs 42/97,42%,p<0.001),未发现PRLs。

关键数值与推荐

  • CVS与PRLs评估采用北美MS影像协作组(NAIMS)标准。
  • 病灶排除最常见原因为大小(n=143,其中大融合病灶n=122,<3 mm n=21)。

临床怎么用

  • 儿童MOGAD中CVS阳性率受MRI采集时机影响,解读时应结合临床分期。
  • CVS+病灶更可能持续存在,可辅助识别活动性或持久性病灶。
  • 未检出PRLs支持将PRLs作为区分MOGAD与MS的影像生物标志物。

局限性

  • 大融合或多静脉病灶比例高,限制了适合CVS分析的病灶比例。
  • 回顾性设计及MRI采集时机差异可能影响CVS检出率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Central vein sign (CVS) is a common feature in multiple sclerosis (MS) lesions, but its frequency in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) varies significantly across studies. Paramagnetic rim lesions (PRLs) are described in MS, but not in MOGAD. Our goals were to evaluate the prevalence of PRLs and CVS in a large multicenter cohort of pediatric MOGAD. We compared CVS frequencies between acute vs remission phases, as well as with longitudinal dynamics of lesion evolution. METHODS: In this longitudinal retrospective multicenter study, clinical MRIs were assessed from pediatric patients with MOGAD, who had (1) ≥1 brain lesion, (2) susceptibility-based imaging (SBI), and (3) follow-up MRI at least 3 months apart. T2-weighted and fluid-attenuated inversion recovery sequences were analyzed for lesion detection and resolution. SBI was used to assess CVS and PRLs following North American Imaging in MS Cooperative criteria. RESULTS: A total of 65 patients and 130 scans were included. A total of 520 lesions were evaluated. The most common reason for lesion exclusion was size (n = 143, large confluent lesions, n = 122, <3 mm, n = 21). CVS was detected in 97 of 327 (29.7%) lesions, with 32 of 65 (49.2%) patients having at least 1 CVS+ lesion. Patients with ≥1 CVS+ lesion (32/65, 49.2%) had a higher number of lesions (p = 0.002) and lesions suitable for CVS analysis (p < 0.001). Of the 31 patients with ≥3 brain lesions, 11 of 31 (35.5%) had >40% CVS+ lesions and 7 (22.5%) had >50% CVS+ lesions. Only 4 patients had ≥6 CVS+ lesions. The proportion of CVS+ lesions was lower in patients who had SBI acquired during an acute attack vs patients scanned during remission (16% vs 33%, p = 0.015). The rate of lesion resolution was higher in CVS- lesions (177/230, 76%) compared with CVS+ (42/97, 42%, p < 0.001). No PRLs were identified. DISCUSSION: Lesion pathobiology in MOGAD is heterogeneous. CVS identified persistent rather than transient lesions, with resolution more common among CVS- lesions. The high frequency of confluent or multivein lesions limited the proportion suitable for CVS analysis. MRI timing influenced CVS detection, which was higher in remission, suggesting that time of acquisition contributes to variability across MOGAD studies. No PRLs were found, supporting their potential as biomarkers distinguishing MOGAD from MS.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Nistri R, Cacciaguerra L, Sacco S, et al. Investigating the Frequency and Outcome of Central Vein Sign and Paramagnetic Rim Lesions in Children With MOGAD. Neurology. 2026. PMID: 41512208. doi:10.1212/WNL.0000000000214410

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。